Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |